Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v6-EN
Language French English
Date Updated 2018-03-10 2018-03-10
Drug Identification Number 02435241 02435241
Brand name DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE
Common or Proper name Dimenhydrinate Injection USP Dimenhydrinate Injection USP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients DIMENHYDRINATE DIMENHYDRINATE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 5 ML 5 ML
ATC code R06AA R06AA
ATC description ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-01 2018-02-01
Estimated end date 2018-03-01 2018-03-01
Actual end date 2018-03-09
Shortage status Actual shortage Resolved
Tier 3 Status No No
Company comments
Health Canada comments